93 related articles for article (PubMed ID: 7648905)
1. [The study of platinum concentration in retroperitoneal lymph nodes after intraperitoneal carboplatin in ovarian tumors].
Liu J; Li M
Zhonghua Fu Chan Ke Za Zhi; 1995 May; 30(5):273-5. PubMed ID: 7648905
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
Miyagi Y; Fujiwara K; Kigawa J; Itamochi H; Nagao S; Aotani E; Terakawa N; Kohno I;
Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
[TBL] [Abstract][Full Text] [Related]
3. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].
Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H
Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of carboplatin after i.v. administration.
Elferink F; van der Vijgh WJ; Klein I; Vermorken JB; Gall HE; Pinedo HM
Cancer Treat Rep; 1987 Dec; 71(12):1231-7. PubMed ID: 3319135
[TBL] [Abstract][Full Text] [Related]
5. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
Chen J; Wang L; Yao Q; Ling R; Li K; Wang H
Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515
[TBL] [Abstract][Full Text] [Related]
6. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of carboplatin in a patient under hemodialysis].
Kurata H; Yoshiya N; Ikarashi H; Kaneko T; Kodama S; Tanaka K; Suzuki K; Yoshizawa H; Cho T; Suzuki E
Gan To Kagaku Ryoho; 1994 Mar; 21(4):547-50. PubMed ID: 8129398
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
Deng C; Huang R; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of pelvic transarterial chemoembolization with lipiodol ultra-fluid carboplatin and transarterial carboplatin through experiment in dogs].
Chen CL; Sun MH; Tan DC; Liang LZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1405-8. PubMed ID: 15566645
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of carboplatin after intraperitoneal administration and clinical effect in ovarian cancer].
Ohno M; Hirokawa M; Hando T
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2355-61. PubMed ID: 1463342
[TBL] [Abstract][Full Text] [Related]
11. Distribution of platinum in human gynecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy.
Ishikawa H; Kikkawa F; Tamakoshi K; Matsuzawa K; Kawai M; Suganuma N; Tomoda Y
Anticancer Res; 1996; 16(6B):3849-53. PubMed ID: 9042269
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of platinum in the female genital tract after intraarterial carboplatin infusion during the operation of uterine cervical cancer].
Nagai N; Murakami T; Ohama K
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1975-9. PubMed ID: 8085848
[TBL] [Abstract][Full Text] [Related]
13. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics study of intraperitoneal carboplatin in gynecologic carcinoma].
Tu C; Meng Y; Yang X
Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):212-4. PubMed ID: 7664606
[TBL] [Abstract][Full Text] [Related]
15. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients.
Chambers SK; Davis CA; Chambers JT; Schwartz PE; Lorber MI; Hschumacher RE
Clin Cancer Res; 1996 Oct; 2(10):1699-704. PubMed ID: 9816119
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer.
Yamamoto R; Kaneuchi M; Nishiya M; Todo Y; Takeda M; Okamoto K; Negishi H; Sakuragi N; Fujimoto S; Hirano T
Cancer Chemother Pharmacol; 2002 Aug; 50(2):137-42. PubMed ID: 12172979
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of intraperitoneal carboplatin administration-- pharmacokinetic analysis].
Ito K; Itani Y; Furuki K; Tamori N; Noda T; Adachi S; Hirano Y; Kato Y; Kiyozuka Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1180-6. PubMed ID: 1453047
[TBL] [Abstract][Full Text] [Related]
19. [Retroperitoneal lymph node metastasis in epithelial cancer of the ovary: a report of 58 cases].
Xie R; Lin YZ; Chen GL
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):499-501. PubMed ID: 15555344
[TBL] [Abstract][Full Text] [Related]
20. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
Shimizu A; Kimura T; Funatsu M; Hada Y; Tamura K; Taguchi A; Miyakawa Z; Notake Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
